Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study

Clinical and Experimental Hypertension : CHE
Tian ShenJin-Ming Yu

Abstract

This study aimed to compare the real-world effectiveness of valsartan and non renin-angiotensin system (non-RAS) agent monotherapy on the incidence of new on-set diabetes (NOD) in Chinese hypertensive patients. It was based on an electronic Health Recording System database from Minhang District of Shanghai. Hypertensive patients aged ≥18 years continuously taking either valsartan or non-RAS agent monotherapy for >12 months were included. Hazard ratios (HR) of NOD events were estimated using propensity score matching method and multivariate regression. Of 29295 patients, there were 2107 in valsartan group, 21397 in CCB group, 4094 in β-blockers group and 1697 in diuretics group. Two-year follow-up revealed NOD rates of 11.09 and 14.22 per 100 persons per year in valsartan and non-RAS inhibitor groups (HR = 0.77, 95% confidence interval 0.65-0.93, P = 0.006), respectively. Among non-RAS agents, CCB group had the highest incidence of NOD (21.72 per 100 persons per year). Comparisons between CCB sub-groups revealed the highest NOD incidence for nifedipine, followed by amlodipine and felodipine. NOD incidences in β-blockers and diuretics groups (11.70 and 10.50 per 100 persons per year, respectively) were not significantly different...Continue Reading

References

Aug 27, 2002·Journal of Hypertension·Lars H LindholmUNKNOWN LIFE study group
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Sverre E KjeldsenUNKNOWN LIFE (Losartan Intervention for Endpoint Reduction) Study Group
Mar 24, 2004·Hypertension·Paolo VerdecchiaCarlo Porcellati
Feb 18, 2005·Journal of Hypertension·Karin A M Jandeleit-DahmMark E Cooper
Aug 27, 2005·Journal of Human Hypertension·B M Y CheungC R Kumana
Jun 24, 2006·Journal of Hypertension·Sverre E KjeldsenUNKNOWN VALUE Trial Investigators
Jul 3, 2007·Pharmacoepidemiology and Drug Safety·Thomas A BurkeGeorge G Rhoads
Jan 4, 2008·Hypertension·Toshio OgiharaUNKNOWN Candesartan Antihypertensive Survival Evaluation in Japan Trial Group
Feb 5, 2008·American Journal of Hypertension·David SiegelArthur L M Swislocki
May 30, 2008·Journal of Human Hypertension·T A AksnesS Julius
Oct 23, 2008·Expert Review of Cardiovascular Therapy·Toshio OgiharaUNKNOWN CASE-J Trial Group
Dec 17, 2008·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 25, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yi-Sheng LiouGwo-Ping Jong
Apr 29, 2009·Archives of Internal Medicine·Dariush MozaffarianDavid Siscovick
May 13, 2009·Archives of Internal Medicine·Jackson T WrightUNKNOWN ALLHAT Collaborative Research Group
May 30, 2009·Vascular Health and Risk Management·Ming-Sheng Zhou, Ivonne Hernandez Schulman
Aug 20, 2009·Cardiovascular Therapeutics·Gwo-Ping JongTsochiang Ma
Nov 11, 2009·Expert Review of Cardiovascular Therapy·Rhonda M Cooper-DeHoffCarl J Pepine
May 26, 2010·Journal of Hypertension·James R SowersPrakash C Deedwania
Nov 3, 2010·International Journal of Cardiology·Deng-feng GengJing-feng Wang
Feb 11, 2011·Current Medical Research and Opinion·Vivian FonsecaPrakash Deedwania
Mar 25, 2011·Environmental Health and Preventive Medicine·Hirokuni HashikataAkio Koizumi
Sep 7, 2011·Annals of Internal Medicine·Jared P ReisArthur Schatzkin
Dec 12, 2012·Journal of the American College of Cardiology·Gianluigi SavaresePasquale Perrone-Filardi
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Jul 17, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Min-Ju KimHyun-Young Park

❮ Previous
Next ❯

Citations

Oct 12, 2018·Clinical and Experimental Hypertension : CHE·Baoxin LiYunliang Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.